Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 8AP6 | Q389Z3 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q586H1 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q57ZM4 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | P0DPG3 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | D0A5R7 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | P0DPG4 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q57VT0 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q387J1 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | C9ZJA0 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q38AG1 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q582T1 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q57Z84 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q38C84 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | C9ZLR9 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | Q583U4 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AP6 | 8AP6 | Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer | |
| 8AX5 | P0AEX9 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881 | |
| 8AX5 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881 | |
| 8AX5 | O60894 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881 | |
| 8AX6 | P0AEX9 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882 | |
| 8AX6 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882 | |
| 8AX6 | O60894 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882 | |
| 8AX7 | P0AEX9 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448 | |
| 8AX7 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448 | |
| 8AX7 | O60894 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448 | |
| 8DCY | 8DCY | CCHFV GP38 Hoti/Kosovo bound with 13G8 Fab | |
| 8DCY | A0A7T6Y557 | CCHFV GP38 Hoti/Kosovo bound with 13G8 Fab | |
| 8DW2 | 8DW2 | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022 | |
| 8DW2 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022 | |
| 8DW3 | 8DW3 | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022 | |
| 8DW3 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022 | |
| 8DWA | P0DTC2 | Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD) | |
| 8DWA | 8DWA | Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD) | |
| 8DXS | P0DTC2 | Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 8DXS | 8DXS | Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 8E56 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
| 8E56 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
| 8E56 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution | |
| 8E57 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution | |
| 8E57 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution | |
| 8E57 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution | |
| 8E58 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E58 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E58 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E59 | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E5A | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54284 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54289 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution |
